Chair: Leeza Osipenko

Discussants:

Pan Pantziarka  

Barbara Goodman

Patricia Vandamme

Beth Boyer 

This event explores regulatory and collaborative best practices in drug repurposing across the US and EU, highlighting initiatives like the US's 505(b)(2) pathway and Project Renewal, and the EU's STAMP Pilot and new legislative proposals (Article 48). With the suspension of the UK's Medicines Repurposing Programme, the event will focus on actionable strategies and international partnership models to ensure the UK remains a vital player in accelerating new, affordable treatments to patients with unmet medical needs.

Sign up